Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic value of K-ras mutations, ras oncoprotein, and c-erb B-2 oncoprotein expression in adenocarcinoma of the lung.

American journal of clinical oncology - 1 Apr 1998

Nemunaitis J, Klemow S, Tong A, Courtney A, Johnston W, Mack M, Taylor W, Solano M, Stone M, Mallams J, Mues G

Abstract excerpt

This trial was undertaken to determine the prognostic role of K-ras (p21), c-erb B-2 (p185) protein expression, and the presence or nonpresence of a K-ras gene mutation in patients with adenocarcinoma of the lung. This was a retrospective study of 103 patients with adeno- or large-cell carcinoma of the lung who had available paraffin-stored tumor material. The relation of several clinical variables to survival...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Genes, ras

Share to Immunohistochemistry

Share to Lung Neoplasms

Share to Mutation

Share to Polymerase Chain Reaction

Source

Identifiers

PMID: 9537203
DOI: 10.1097/00000421-199804000-00013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Prognostic value of K-ras mutations, ras oncoprotein, and c-erb B-2 oncoprotein expression in adenocarcinoma of the lung.PMID 9537203Read ↗

C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.Semantic proximity Read ↗

K-ras oncogene mutation as a prognostic marker in non-small cell lung cancer: a combined analysis of 881 cases.Semantic proximity Read ↗

K-RAS and P53 mutations in association with COX-2 and hTERT expression and clinico-pathological status of NSCLC patients.Semantic proximity Read ↗

Detection of K-ras mutations in lung carcinomas: relationship to prognosis.Semantic proximity Read ↗

Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer.Semantic proximity Read ↗

Overexpression of the c‐erbB‐2/neu–encoded p185 protein in primary lung cancerSemantic proximity Read ↗

Serum and tissue c-erb B2, bcl-2, and mutant p53 oncoprotein levels in nasopharyngeal cancer.Semantic proximity Read ↗

Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study.Semantic proximity Read ↗

Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas.Semantic proximity Read ↗

Prognostic significance of expression patterns of c-erbB-2, p53, p16<sup>INK4A</sup>, p27<sup>KIP1</sup>, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray studySemantic proximity Read ↗

Clinicopathologic analysis of k-ras, p53, and ERBB-2 gene alterations in pulmonary adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.